Glibenclamide/metformin

Glibenclamide/Metformin is a combination medication used in the treatment of type 2 diabetes. It contains two active ingredients: glibenclamide, a sulfonylurea, and metformin, a biguanide. This combination therapy is designed to improve blood sugar control in people whose diabetes cannot be controlled by diet and exercise alone.

Mechanism of Action

Glibenclamide works by stimulating the pancreas to produce more insulin, a hormone that regulates the amount of glucose in the blood. Metformin, on the other hand, reduces the amount of glucose produced by the liver and improves the body's response to insulin. Together, these two drugs help to lower blood sugar levels and control type 2 diabetes.

Usage and Dosage

The dosage of Glibenclamide/Metformin is individualized based on the patient's blood sugar levels and response to treatment. It is usually taken orally, with meals, to reduce the risk of an upset stomach. Patients are advised to follow a regular exercise and diet regimen alongside this medication for optimal results.

Side Effects

Common side effects of Glibenclamide/Metformin include nausea, upset stomach, and diarrhea. In rare cases, it can cause lactic acidosis, a serious metabolic condition. Patients are advised to seek immediate medical attention if they experience symptoms such as rapid breathing, severe nausea or vomiting, or unexplained tiredness.

Precautions

Before starting Glibenclamide/Metformin, patients should inform their healthcare provider about any existing medical conditions such as kidney or liver disease, certain hormonal conditions, or if they are pregnant or planning to become pregnant.

Interactions

Glibenclamide/Metformin may interact with other medications, including other diabetes medications, certain antibiotics, and some high blood pressure drugs. Patients should always inform their healthcare provider about all the medications they are currently taking.